Physician profile

Stephanie Koh

Interventional Cardiology · Sugar Land, TX

NPI 1639523897

$7,996.94

in general payments reported to CMS, 2019-2025

16 companies · $205 in 2025

The $205 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).

See the full distribution for Interventional Cardiology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$2,612.14
Travel and Lodging$1,210.57
Education$1.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbott Laboratories $4,215.92 2019-2024 Supera, Absolute Pro, Amplatzer Talisman
Boston Scientific Corporation $1,015.67 2022-2023 Resonate El Icd Vr
Edwards Lifesciences Corporation $564.07 2023 Edwards Sapien 3 Transcatheter Heart Valve (Thv)
Inari Medical, INC. $284.02 2022-2023 Ct Thrombectomy System Kit, Flowtriever Catheter, S
Cardiovascular Systems INC. $277.57 2022-2023 Diamondback Coronary
Astrazeneca Pharmaceuticals LP $253.18 2019-2021
Amgen INC. $228.32 2019-2022
Philips North America LLC $124.99 2023
Penumbra, INC. $111.67 2025 Indigo System
Medtronic, INC. $66.23 2023 Hawkone, Selectsecure
Cathworks, INC. $44.96 2022
Angiodynamics, INC. $43.28 2025 Alphavac
Teleflex LLC $39.80 2023-2025 Guideliner, Supercross
Chiesi USA, INC. $30.28 2022
Abbvie INC. $27.87 2025
Show all 16 companies
CompanyGeneral paymentsYearsTop products
Heartflow, INC. $19.20 2024

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Stephanie Koh

$7,996.94

in general payments reported 2019-2025

Years
2019-2025
Top company
Abbott Laboratories
Context
The $205 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).

https://glasscript.com/doctor/7228191/stephanie-koh

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.